Progress on Genetic Basis of Primary Aldosteronism

Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduction of aldosterone with simultaneous suppression of plasma renin activity (PRA). It is considered to be the most common endocrine cause of secondary arterial hypertension (HT) and is associated with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Izabela Karwacka, Łukasz Obołończyk, Sonia Kaniuka-Jakubowska, Michał Bohdan, Krzysztof Sworczak
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/fa1f82f2f734431ab5daddcf1a8c0822
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa1f82f2f734431ab5daddcf1a8c0822
record_format dspace
spelling oai:doaj.org-article:fa1f82f2f734431ab5daddcf1a8c08222021-11-25T16:51:05ZProgress on Genetic Basis of Primary Aldosteronism10.3390/biomedicines91117082227-9059https://doaj.org/article/fa1f82f2f734431ab5daddcf1a8c08222021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1708https://doaj.org/toc/2227-9059Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduction of aldosterone with simultaneous suppression of plasma renin activity (PRA). It is considered to be the most common endocrine cause of secondary arterial hypertension (HT) and is associated with a high rate of cardiovascular complications. PA is most often caused by a bilateral adrenal hyperplasia (BAH) or aldosterone-producing adenoma (APA); rarer causes of PA include genetic disorders of steroidogenesis (familial hyperaldosteronism (FA) type I, II, III and IV), aldosterone-producing adrenocortical carcinoma, and ectopic aldosterone-producing tumors. Over the last few years, significant progress has been made towards understanding the genetic basis of PA, classifying it as a channelopathy. Recently, a growing body of clinical evidence suggests that mutations in ion channels appear to be the major cause of aldosterone-producing adenomas, and several mutations within the ion channel encoding genes have been identified. Somatic mutations in four genes (<i>KCNJ5</i>, <i>ATP1A1</i>, <i>ATP2B3</i> and <i>CACNA1D</i>) have been identified in nearly 60% of the sporadic APAs, while germline mutations in <i>KCNJ5</i> and <i>CACNA1H</i> have been reported in different subtypes of familial hyperaldosteronism. These new insights into the molecular mechanisms underlying PA may be associated with potential implications for diagnosis and therapy.Izabela KarwackaŁukasz ObołończykSonia Kaniuka-JakubowskaMichał BohdanKrzysztof SworczakMDPI AGarticleprimary aldosteronismfamilial hyperaldosteronismion channelsaldosterone-producing adenoma<i>KCNJ5</i><i>ATP1A1</i>Biology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1708, p 1708 (2021)
institution DOAJ
collection DOAJ
language EN
topic primary aldosteronism
familial hyperaldosteronism
ion channels
aldosterone-producing adenoma
<i>KCNJ5</i>
<i>ATP1A1</i>
Biology (General)
QH301-705.5
spellingShingle primary aldosteronism
familial hyperaldosteronism
ion channels
aldosterone-producing adenoma
<i>KCNJ5</i>
<i>ATP1A1</i>
Biology (General)
QH301-705.5
Izabela Karwacka
Łukasz Obołończyk
Sonia Kaniuka-Jakubowska
Michał Bohdan
Krzysztof Sworczak
Progress on Genetic Basis of Primary Aldosteronism
description Primary aldosteronism (PA) is a heterogeneous group of disorders caused by the autonomous overproduction of aldosterone with simultaneous suppression of plasma renin activity (PRA). It is considered to be the most common endocrine cause of secondary arterial hypertension (HT) and is associated with a high rate of cardiovascular complications. PA is most often caused by a bilateral adrenal hyperplasia (BAH) or aldosterone-producing adenoma (APA); rarer causes of PA include genetic disorders of steroidogenesis (familial hyperaldosteronism (FA) type I, II, III and IV), aldosterone-producing adrenocortical carcinoma, and ectopic aldosterone-producing tumors. Over the last few years, significant progress has been made towards understanding the genetic basis of PA, classifying it as a channelopathy. Recently, a growing body of clinical evidence suggests that mutations in ion channels appear to be the major cause of aldosterone-producing adenomas, and several mutations within the ion channel encoding genes have been identified. Somatic mutations in four genes (<i>KCNJ5</i>, <i>ATP1A1</i>, <i>ATP2B3</i> and <i>CACNA1D</i>) have been identified in nearly 60% of the sporadic APAs, while germline mutations in <i>KCNJ5</i> and <i>CACNA1H</i> have been reported in different subtypes of familial hyperaldosteronism. These new insights into the molecular mechanisms underlying PA may be associated with potential implications for diagnosis and therapy.
format article
author Izabela Karwacka
Łukasz Obołończyk
Sonia Kaniuka-Jakubowska
Michał Bohdan
Krzysztof Sworczak
author_facet Izabela Karwacka
Łukasz Obołończyk
Sonia Kaniuka-Jakubowska
Michał Bohdan
Krzysztof Sworczak
author_sort Izabela Karwacka
title Progress on Genetic Basis of Primary Aldosteronism
title_short Progress on Genetic Basis of Primary Aldosteronism
title_full Progress on Genetic Basis of Primary Aldosteronism
title_fullStr Progress on Genetic Basis of Primary Aldosteronism
title_full_unstemmed Progress on Genetic Basis of Primary Aldosteronism
title_sort progress on genetic basis of primary aldosteronism
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/fa1f82f2f734431ab5daddcf1a8c0822
work_keys_str_mv AT izabelakarwacka progressongeneticbasisofprimaryaldosteronism
AT łukaszobołonczyk progressongeneticbasisofprimaryaldosteronism
AT soniakaniukajakubowska progressongeneticbasisofprimaryaldosteronism
AT michałbohdan progressongeneticbasisofprimaryaldosteronism
AT krzysztofsworczak progressongeneticbasisofprimaryaldosteronism
_version_ 1718412934805192704